For triathletes and other athletes training long hours and pushing performance boundaries, the physiological impact of GLP-1 drugs could carry serious consequences
In intact rats, chronic hexarelin treatment (50 g/kg twice daily for 60 days) improved BMC (+6.5%) and bone area (+4.1%) at lumbar vertebrae
Glucagon-like peptide-1 receptor agonists and anesthesia - Are we clearer on the correct approach
In addition, more than 40% of CagriSema-treated participants achieved weight loss of at least 25%, versus 6% of patients taking cagrilintide, 16.2% of those on semaglutide and 0.9% of participants in the placebo group
When evaluating providers, ask whether they offer both semaglutide and tirzepatide, what their protocol is for switching between medications, and whether their clinical team has experience managing patients on multiple GLP-1 platforms
The muscle protection they lost by stopping was real